Review of Pulmonary Hemorrhage (PH) in Non–Small-Cell Lung Cancer (NSCLC) Subjects Receiving Bevacizumab and Cisplatin plus Gemcitabine on Protocol BO17704
F. LaFleur, J. Skillings, V. Hirsh, J. Bennouna, H.-P. Kuo, B. Szima, M. Gottfried, A. Kunitsyn, J.M. Trigo, G.-C. Chang, J. Cosaert, M. ReckVolume:
8
Year:
2007
Language:
english
DOI:
10.1016/s1525-7304(11)70812-9
File:
PDF, 450 KB
english, 2007